Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Max Nieuwdorp

Showing results (161-170 of 415) with videos related to

Pageof 42
Sort By:
Hepatology Communications|November 5, 2022
Noninvasive tests for nonalcoholic fatty liver disease in a multi-ethnic population: The HELIUS studyAnne-Marieke van Dijk, Yasaman Vali, Anne Linde Mak, et al.
Metabolism: Clinical and Experimental|April 18, 2016
Impaired insulin action in the liver, but not in adipose tissue or muscle, is a distinct metabolic feature of impaired fasting glucose in obese humansKasper W Ter Horst, Pim W Gilijamse, Mariette T Ackermans, et al.
Plos One|November 16, 2013
Role of tumor necrosis factor-α in the human systemic endotoxin-induced transcriptomeBrendon P Scicluna, Cornelis van 't Veer, Max Nieuwdorp, et al.
Antioxidants (Basel, Switzerland)|July 29, 2025
Does Gut Microbial Methylglyoxal Metabolism Impact Human Physiology?Oluwatomisono I Akinrimisi, Kim Maasen, Jean L J M Scheijen, et al.
International Journal of Molecular Sciences|October 16, 2025
Intestinal <i>Myo</i>-Inositol Metabolism and Metabolic Effects of <i>Myo</i>-Inositol Utilizing <i>Anaerostipes rhamnosivorans</i> in MiceAldo Grefhorst, Antonella S Kleemann, Stefan Havik, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 4, 2017
SGLT2 Inhibition in the Diabetic Kidney-From Mechanisms to Clinical OutcomeErik J M van Bommel, Marcel H A Muskiet, Lennart Tonneijck, et al.
Gastroenterology|February 12, 2018
The Duodenum harbors a Broad Untapped Therapeutic PotentialAnnieke C G van Baar, Max Nieuwdorp, Frits Holleman, et al.
Genome Medicine|March 21, 2024
Ethnic variations in metabolic syndrome components and their associations with the gut microbiota: the HELIUS studyManon Balvers, Marcus de Goffau, Natal van Riel, et al.
Gastrointestinal Endoscopy|May 1, 2024
Recellularization via electroporation therapy of the duodenum combined with glucagon-like peptide-1 receptor agonist to replace insulin therapy in patients with type 2 diabetes: 12-month results of a first-in-human studyCeline B E Busch, Suzanne Meiring, Annieke C G van Baar, et al.
Nature Communications|December 6, 2022
The gut microbiota and depressive symptoms across ethnic groupsJos A Bosch, Max Nieuwdorp, Aeilko H Zwinderman, et al.
Pageof 42

Showing results (161-170 of 415) with videos related to

Sort By:
Pageof 42
Hepatology Communications|November 5, 2022
Noninvasive tests for nonalcoholic fatty liver disease in a multi-ethnic population: The HELIUS studyAnne-Marieke van Dijk, Yasaman Vali, Anne Linde Mak, et al.
Metabolism: Clinical and Experimental|April 18, 2016
Impaired insulin action in the liver, but not in adipose tissue or muscle, is a distinct metabolic feature of impaired fasting glucose in obese humansKasper W Ter Horst, Pim W Gilijamse, Mariette T Ackermans, et al.
Plos One|November 16, 2013
Role of tumor necrosis factor-α in the human systemic endotoxin-induced transcriptomeBrendon P Scicluna, Cornelis van 't Veer, Max Nieuwdorp, et al.
Antioxidants (Basel, Switzerland)|July 29, 2025
Does Gut Microbial Methylglyoxal Metabolism Impact Human Physiology?Oluwatomisono I Akinrimisi, Kim Maasen, Jean L J M Scheijen, et al.
International Journal of Molecular Sciences|October 16, 2025
Intestinal <i>Myo</i>-Inositol Metabolism and Metabolic Effects of <i>Myo</i>-Inositol Utilizing <i>Anaerostipes rhamnosivorans</i> in MiceAldo Grefhorst, Antonella S Kleemann, Stefan Havik, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 4, 2017
SGLT2 Inhibition in the Diabetic Kidney-From Mechanisms to Clinical OutcomeErik J M van Bommel, Marcel H A Muskiet, Lennart Tonneijck, et al.
Gastroenterology|February 12, 2018
The Duodenum harbors a Broad Untapped Therapeutic PotentialAnnieke C G van Baar, Max Nieuwdorp, Frits Holleman, et al.
Genome Medicine|March 21, 2024
Ethnic variations in metabolic syndrome components and their associations with the gut microbiota: the HELIUS studyManon Balvers, Marcus de Goffau, Natal van Riel, et al.
Gastrointestinal Endoscopy|May 1, 2024
Recellularization via electroporation therapy of the duodenum combined with glucagon-like peptide-1 receptor agonist to replace insulin therapy in patients with type 2 diabetes: 12-month results of a first-in-human studyCeline B E Busch, Suzanne Meiring, Annieke C G van Baar, et al.
Nature Communications|December 6, 2022
The gut microbiota and depressive symptoms across ethnic groupsJos A Bosch, Max Nieuwdorp, Aeilko H Zwinderman, et al.
Pageof 42